Riskpilot← Back to searchSign inGet full accessDoktor Ruben Innovation AB
ABActiveOrg 5565872610Cederborgsvägen 7Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20001 employees
Revenue 2025
SEK 0
EBITDA margin
—
-343% vs 2024
Equity ratio
86.5%
Financial strength
Net profit 2025
SEK 215K
-50% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -128K | -343% |
| Net profit | SEK 215K | -50% |
| Total assets | SEK 7,8M | -5% |
| Equity | SEK 6,7M | +0% |
| Employees | 1 | — |
Legal name
Doktor Ruben Innovation AB
Org number
5565872610
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
12 maj 2000
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall uppfinna, utveckla, tillverka samt bedriva handel med och marknadsföring av produkter för förbättring av hälsa och ökad livskvalitet utföra konsultationer inom samma område, idka personaluthyrning inom hälsosektorn jämte därmed förenlig verksamhet samt köp och försäljning av fast och lös egendom företrädesvis värdepapper.
Address
Cederborgsvägen 7
Email
docruben@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 474 | 1 712 | 1 101 | 305 | 0 |
| Staff expenses | — | −60 | −46 | −46 | −22 |
| EBITDA | 306 | 1 400 | 829 | 53 | −128 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 306 | 1 400 | 829 | 53 | −128 |
| Net financials | 64 | — | −507 | 52 | 72 |
| Profit before tax | 346 | 1 450 | 560 | 568 | 282 |
| Tax | −81 | −314 | −165 | −135 | −67 |
| Net profit | 265 | 1 136 | 395 | 433 | 215 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 475 | 8 871 | 8 698 | 8 163 | 7 775 |
| Equity | 5 297 | 6 249 | 6 460 | 6 703 | 6 727 |
| Long-term debt | 2 | 2 | 2 | 2 | 2 |
| Short-term debt | 133 | 629 | 483 | 168 | 94 |
| Total debt | 135 | 630 | 485 | 170 | 95 |
EBITDA margin
-12783200.0%
This company
15.8%
Market median
-80906429% vs market
20212025
Equity ratio
86.5%
This company
38.2%
Market median
+126% vs market
20212025
Return on equity
3.2%
This company
18.4%
Market median
-83% vs market
20212025
Net profit margin
21464800.0%
This company
8.1%
Market median
+264997431% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Ruben Innovation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Ruben Lindgren | Board of Directors | 0 companies |
| Karl Ola Bergström | Deputy Board Member | 0 companies |